Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment

Combination chemotherapy is a common clinical practice in cancer treatment. Here, cyclic RGD (arginylglycylaspartic acid) peptide was introduced to the surface of lipid/calcium/phosphate (LCP) asymmetric lipid layer nanoparticles for the co-delivery of paclitaxel (PTX) and gemcitabine monophosphate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Zhang, Peng, Zou, Qian, Li, Xiang, Fu, Jianjiang, Luo, Ying, Liang, Xinli, Jin, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278289/
https://www.ncbi.nlm.nih.gov/pubmed/30405089
http://dx.doi.org/10.3390/molecules23112906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278289/
https://www.ncbi.nlm.nih.gov/pubmed/30405089
http://dx.doi.org/10.3390/molecules23112906

Ejemplares similares